Expert FDA Meeting Preparation Services
Elexes helps medical device manufacturers prepare for productive FDA interactions with strategic meeting planning, briefing package support, mock sessions, and response guidance. From Pre-Subs to Type C discussions, our consultants help teams present clear questions, defensible data, and well-structured regulatory positions that reduce avoidable delays and strengthen the path toward submission and market progress.
Our FDA Meeting Preparation Services
Strategic support for FDA meeting planning, briefing materials, readiness reviews, and follow-up actions.
Pre-Sub Support
Prepare for FDA Q-Sub and Pre-Sub interactions with meeting strategy, question framing, mock sessions, and briefing package development designed to improve clarity and reviewer engagement.
Submission Readiness
Assess whether your device, evidence, and documentation are ready to support productive FDA discussions before formal submission or re-engagement with the agency.
Agency Response
Get structured support responding to FDA questions, deficiency letters, and follow-up requests with clear, defensible, and well-organized regulatory communications.
510(k) Strategy
Align meeting objectives with your 510(k) pathway, predicate strategy, testing plans, intended use language, and documentation priorities before submission.
Compliance Assessment
Identify regulatory gaps across technical documentation, risk management, quality systems, and evidence packages that could weaken your FDA meeting position.
Regulatory Strategy
Build a tailored FDA engagement strategy that supports efficient decision-making, stronger meeting outcomes, and better alignment with broader global market plans.
Our FDA Meeting Preparation Process
Define Meeting Goals And Pathway
We start by clarifying the purpose of the FDA interaction, whether it is a Pre-Sub, Type C meeting, or another strategic engagement. Our team aligns your questions, device status, and regulatory pathway so the meeting has a focused objective.
Review Evidence And Documentation
Next, we assess your technical documentation, testing plans, risk files, clinical rationale, and quality system inputs to identify gaps that could weaken your position. This helps ensure your briefing package is supported by consistent, defensible evidence.
Draft Questions And Briefing Package
We help structure concise, decision-oriented questions and organize the supporting background the FDA needs to respond effectively. The package is written to reduce ambiguity, highlight key facts, and keep reviewers focused on the issues that matter most.
Conduct Mock Meeting Preparation
Before the live meeting, we run mock sessions to prepare your team for likely FDA questions, presentation flow, and speaking roles. This improves confidence, sharpens messaging, and helps internal stakeholders stay aligned under time constraints.
Support Follow-Up And Next Actions
After the meeting, we help interpret FDA feedback, document action items, and translate discussion outcomes into a practical regulatory plan. That may include submission remediation, additional testing, or preparation for the next agency interaction.
Trusted By Manufacturers
Success Stories
Supporting medical device teams through complex regulatory decisions with structured, submission-focused FDA meeting preparation.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for disciplined regulatory preparation and practical FDA meeting support.
Deep Expertise
50+ years of collective experience across FDA, ISO, and global medical device regulations.
End-To-End
Support spans strategy, documentation, mock meetings, submissions, and post-meeting remediation planning.
Proven Results
250+ successful projects and 200+ product types supported across complex regulatory pathways.
Flexible Support
Project-based, part-time, or embedded consulting models fit your team structure and timelines.
Meet The Elexes Team
Experienced regulatory specialists supporting critical FDA interactions.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device manufacturers navigate complex regulatory pathways with clarity and discipline. Over the years, the company has supported global clients across FDA submissions, quality systems, clinical documentation, and market access strategy. For FDA meeting preparation, Elexes brings together regulatory, quality, and technical expertise to help teams enter agency discussions with stronger documentation, sharper questions, and a more defensible position. The company’s approach is practical and evidence-driven: identify gaps early, prepare thoroughly, communicate clearly, and keep every meeting aligned with the broader approval strategy. That focus has helped Elexes become a trusted consulting partner for startups, scaling manufacturers, and established device companies alike.
50+ YearsCollective regulatory and compliance experience250+ ProjectsSuccessful engagements across device programs90% Audits ClearedStrong quality and inspection readiness outcomes
Frequently Asked Questions
What is a type C FDA meeting?
A Type C FDA meeting is any meeting that does not fall under Type A or Type B categories. It is commonly used to discuss specific scientific, clinical, testing, regulatory, or submission issues that need FDA feedback. For medical device companies, Type C meetings can help clarify expectations, resolve development questions, and reduce uncertainty before major submission or change decisions.
What is the timeline for a Type C meeting?
Preparation timelines vary by meeting type and complexity, but most FDA meetings require several weeks of coordinated work. That typically includes evidence review, gap identification, question drafting, briefing package development, internal alignment, and mock meeting rehearsal. Complex devices, software-heavy products, or meetings involving clinical strategy often need more preparation time to ensure the package is complete, consistent, and strategically focused.
When should a company request an FDA Pre-Sub meeting?
A company should request an FDA Pre-Sub meeting when it needs agency feedback before filing a formal submission, especially on testing strategy, predicate selection, clinical evidence, software documentation, labeling, or regulatory pathway. Requesting feedback early can prevent costly rework, reduce the risk of avoidable deficiencies, and help align internal teams around FDA expectations before timelines become compressed.
What should be included in an FDA meeting briefing package?
An FDA meeting briefing package should include a clear device overview, regulatory history, intended use, specific questions for FDA, supporting technical or clinical context, and any relevant testing or risk information. The package should be concise, logically organized, and written to help reviewers understand the issue quickly. Strong briefing packages focus on decision points rather than overwhelming the agency with unnecessary detail.
How do mock FDA meetings help manufacturers?
Mock FDA meetings help manufacturers rehearse likely reviewer questions, refine speaking roles, improve presentation flow, and identify weak points before the actual interaction. They are especially useful when multiple internal stakeholders are involved or when the discussion includes complex technical issues. A well-run mock session improves confidence, sharpens messaging, and reduces the chance of unclear or inconsistent responses during the live meeting.
Can FDA meeting preparation improve 510(k) submission outcomes?
Yes. Effective FDA meeting preparation can improve 510(k) outcomes by validating key assumptions before submission, such as predicate strategy, performance testing scope, software documentation expectations, and labeling positions. When manufacturers ask focused questions and present well-supported data, they are more likely to receive actionable feedback that strengthens the submission package and reduces the likelihood of delays caused by preventable Additional Information requests.
What happens after an FDA meeting?
After an FDA meeting, the company should review the discussion carefully, confirm action items, and align next steps with the feedback received. This may involve updating the regulatory strategy, revising testing plans, remediating documentation gaps, or preparing a formal submission. Meeting outcomes are most valuable when they are translated into a documented execution plan with responsibilities, timelines, and clear regulatory rationale.
Does Elexes support regulatory interactions beyond FDA meetings?
Yes. Elexes supports FDA meeting preparation as well as broader regulatory strategy across multiple authorities, including Health Canada, TGA, EU MDR, and other global frameworks. For companies managing multi-market plans, this is valuable because FDA meeting positions often affect documentation, testing, and claims used elsewhere. The team helps ensure your FDA interaction supports a coherent overall regulatory pathway rather than creating downstream conflicts.
Still Have Questions About FDA Meetings?
Talk with our regulatory consultants about your meeting strategy.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance knowledge
